Cover image of the article: Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Image Credit:Hepat Mon

Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Authors

Seyed Hashemi, Fariba Jalali, Eskandar Hajiani1,*
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Emam Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: Eskandar Hajiani, M.D. Associate Professor of Gastroenterology and Hepatology, Ahvaz Golestan Hospital, P.O. Box 89, Ahvaz, Iran. Tel: +98 611 553 0222 Fax: +98 611 334 0074, Email: ehajiani@ajums.ac.ir

Hepatitis Monthly:Vol. 9, issue 4; 287-292
Published online:Dec 31, 2009
Article type:Research Article
Received:Nov 06, 2008
Accepted:Jun 01, 2009
How to Cite:Hashemi S, Jalali F, Hajiani E. Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4):. doi:

Abstract

 

Background & Aims: Hepatitis B virus (HBV) and hepatitis D virus (HDV) infections are major health problems in Iran. Preliminary reports indicate that HDV infection, a satellite virus of HBV, exists in this area. However, its prevalence in patients with different types of liver diseases has not been studied in detail. This study was carried out to determine the seroprevalence of HDV among individuals who tested positive for hepatitis B surface antigen (HBsAg) in a southwestern province of Iran.

Methods: In this cross-sectional study a total of 1,725 consecutive patients with HBV liver diseases attending the Ahwaz JundiShapur University Hospitals (AJSUH) and Hepatitis Clinics from 2002 to 2008 were included. We performed tests for HBV and HDV serum markers, using commercially available enzyme-linked immunosorbent assay kits. Patients were split into two groups according to their HDV antibody (anti-HDV) status (HDV positive or negative). The collected data were coded, and the statistical analyses were conducted.

Results: The mean age of the patients was 37 ± 13/8 years. There were 1,157 males and 568 females. Of the 1,725 patients with HBV liver disease, 150 were found to be reactive for anti-delta antibodies, yielding an overall HDV seroprevalence of 11.5%. Anti-HDV was found in 3.59% of patients with inactive chronic hepatitis, 45.5% of patients with chronic active hepatitis, and 43.2% of cirrhotic and hepatocellular carcinoma patients (P < 0.001). A higher proportion of individuals testing positive for antibodies to HDV were observed among males (72%) than among females (28%). The patients without HDV infection were younger than anti-HDV-positive/HBsAg-positive patients (P < 0.01).

Conclusions: HDV infection was common in patients with HBV in our community. All HBV patients should be screened for HDV infection. The results indicate that HDV co-infection was related to the severity of the liver disease. More studies designed to elucidate HDV's epidemiology are needed.

 

Highlights

Fulltext

Full text is available in PDF

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
Aug
2013
Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012

Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012

Masood Ziaee,
Ghodsieh Azarkar

Ziaee M, Azarkar G. Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012. Hepat Mon. 2013;13(8):e11168. doi: https://doi.org/10.5812/hepatmon.11168

6
May
2017
Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014

Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014

Gholamreza Sharifzadeh,
Mohammad Hasan Namaei,
Azadeh Ebrahimzadeh,
Zohreh Azarkar,
Mohammad Fereidouni,
Bita Bijari
,et al.

Sharifzadeh G, Namaei MH, Ebrahimzadeh A, Azarkar Z, Fereidouni M, et al. Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014. Hepat Mon. 2017;17(5):e42866. doi: https://doi.org/10.5812/hepatmon.42866

31
Dec
2008
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004

Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004

Seyed Alireza Taghavi,
Shabnam Sedighi,
Davood Mehrabani,
Farnaz Khademolhoesseini

Taghavi S, Sedighi S, Mehrabani D, Khademolhoesseini F. Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004. Hepat Mon. 2008;8(4):. doi:

30
Jun
2010
A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran

A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran

Sirus Seifi,
Masoud Sabouri Ghannad

Seifi S, Sabouri Ghannad M. A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran. Hepat Mon. 2010;10(2):. doi:

30
Jun
2010
A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran

A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran

S Gltuna,
I Yksel,
O Ba?ar,
O skdar,
Seyfettin Köklü

Gltuna S, Yksel I, Ba?ar O, skdar O, Köklü S. A Study of HDV in HBsAg Positive Patients in Tabriz, Northwestern Iran. Hepat Mon. 2008;8(4):. doi:

More by these authors

Seyed HashemiPubMedScholar
Fariba JalaliPubMedScholar
Eskandar HajianiPubMedScholar
Share
Cited by
Metrics